Quarterly report pursuant to Section 13 or 15(d)

Revenues (Tables)

v3.21.1
Revenues (Tables)
3 Months Ended
Mar. 31, 2021
Revenues  
Schedule of revenues disaggregated by category

Revenues disaggregated by category were as follows (in thousands):

​

​

​

​

​

​

​

​

​

​

Three Months Ended 

​

​

March 31, 

​

​

2021

    

2020

Product sales:

​

​

​

​

​

​

Gross product sales

​

$

16,109

​

$

15,371

Discounts and allowances

​

​

(3,733)

​

​

(2,691)

Total product sales, net

​

​

12,376

​

​

12,680

Revenues from collaborations:

​

​

​

​

​

​

License revenues

​

​

64,618

​

​

39,858

Research and development services and others

​

​

1,024

​

​

3,223

Total revenues from collaborations

​

​

65,642

​

​

43,081

Government contract

​

​

3,000

​

​

—

Total revenues

​

$

81,018

​

$

55,761

Schedule of revenues from product sales disaggregated by customers

The following table summarizes the percentages of revenues from each of our customers who individually accounted for 10% or more (wherein * denotes less than 10%) of the total net product sales and revenues from collaborations:

​

​

​

​

​

​

​

​

​

​

March 31, 

​

​

2021

    

2020

Lilly

​

​

78%

​

​

—

Grifols

​

​

*

​

​

77%

ASD Healthcare and Oncology Supply

​

​

*

​

​

12%

Schedule of product revenue allowance and reserve categories

The following table summarizes activity in each of the product revenue allowance and reserve categories for the three months ended March 31, 2021 and 2020 (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Chargebacks,

​

Government

​

​

​

​

​

​

Discounts and

​

and Other

​

​

​

​

​

​

Fees

​

Rebates

​

Returns

​

Total

Balance at January 1, 2021

    

$

2,461

 

$

2,115

​

$

1,489

​

$

6,065

Provision related to current period sales

​

​

1,952

​

​

1,146

​

​

201

​

​

3,299

Credit or payments made during the period

​

​

(2,727)

​

​

(988)

​

​

(243)

​

​

(3,958)

Balance at March 31, 2021

 

$

1,686

​

$

2,273

​

$

1,447

​

$

5,406

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Chargebacks,

​

Government

​

​

​

​

​

​

​

​

Discounts and

​

and Other

​

​

​

​

​

​

​

​

Fees

​

Rebates

​

Returns

​

Total

Balance at January 1, 2020

    

$

1,293

 

$

1,801

​

$

238

​

$

3,332

Provision related to current period sales

​

​

1,487

​

​

745

​

​

—

​

​

2,232

Credit or payments made during the period

​

​

(1,324)

​

​

(627)

​

​

(58)

​

​

(2,009)

Balance at March 31, 2020

 

$

1,456

​

$

1,919

​

$

180

​

$

3,555